APA (7th ed.) Citation

Honig, L. S., Sabbagh, M. N., van Dyck, C. H., Sperling, R. A., Hersch, S., Matta, A., . . . Kramer, L. (2024). Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease. Alzheimer's Research & Therapy, 16(1), 1. https://doi.org/10.1186/s13195-024-01507-7

Chicago Style (17th ed.) Citation

Honig, Lawrence S., et al. "Correction: Updated Safety Results from Phase 3 Lecanemab Study in Early Alzheimer's Disease." Alzheimer's Research & Therapy 16, no. 1 (2024): 1. https://doi.org/10.1186/s13195-024-01507-7.

MLA (9th ed.) Citation

Honig, Lawrence S., et al. "Correction: Updated Safety Results from Phase 3 Lecanemab Study in Early Alzheimer's Disease." Alzheimer's Research & Therapy, vol. 16, no. 1, 2024, p. 1, https://doi.org/10.1186/s13195-024-01507-7.